Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 86,442 | 120,343 | 62,061 | 58,252 | 71,446 |
| Gross Profit | 86,442 | 120,343 | 62,061 | 58,252 | 71,446 |
| Operating Expenses | 11,110 | 8,820 | 9,410 | 5,526 | 5,255 |
| Operating Income | 75,332 | 111,523 | 52,651 | 52,726 | 66,191 |
| Interest Expense | 9,928 | 11,560 | 12,527 | 9,321 | 3,105 |
| Other Income | -2,187 | -16,237 | 80 | 144 | 537 |
| Pre-tax Income | 63,217 | 83,726 | 40,204 | 43,549 | 63,623 |
| Income Tax | 23,028 | 33,588 | 14,197 | 14,989 | 17,217 |
| Net Income Continuous | 40,189 | 50,138 | 26,007 | 28,560 | 46,406 |
| Net Income | $40,189 | $50,138 | $26,007 | $28,560 | $46,406 |
| EPS Basic Total Ops | 0.32 | 0.42 | 0.22 | 0.24 | 0.39 |
| EPS Basic Continuous Ops | 0.32 | 0.42 | 0.22 | 0.24 | 0.39 |
| EPS Diluted Total Ops | 0.24 | 0.30 | 0.15 | 0.08 | 0.29 |
| EPS Diluted Continuous Ops | 0.23 | 0.29 | 0.14 | 0.08 | 0.28 |
| EBITDA(a) | $77,571 | $113,830 | $55,067 | $54,517 | $66,742 |